AxoGen, Inc.
AxoGen, Inc. (AXGN) Stock Overview
Explore AxoGen, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.7B
P/E Ratio
-96.31
EPS (TTM)
$-0.34
ROE
-0.13%
AXGN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of AxoGen, Inc. (AXGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 52.19, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $32.95.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -96.31 and a market capitalization of 1.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.